0 NASDAQ Companies - February 25, 2019Cellectar Reports Positive Top-line Response Rate of 30% from R/R Multiple Myeloma Cohort in Ongoing Phase 2 Study of CLR 131Read More
0 NASDAQ Companies - February 25, 2019Chembio Diagnostics to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019Read More
0 NASDAQ Companies - February 25, 2019Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for MydriasisRead More
0 NASDAQ Companies - February 25, 2019Establishment Labs to Announce Fourth Quarter and Full Year 2018 Financial ResultsRead More
0 TSX Venture News - February 25, 2019Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical TrialRead More
0 TSX Venture News - February 25, 2019K92 Receives More High-Grade Kora Drill Results From Kora North ExtensionRead More
0 TSX Venture News - February 25, 2019Viva Gold Intersects 33.5 meters at 2.6 grams/tonne Gold at Tonopah Project, NevadaRead More
